Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial

Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Related topics were updated to include 'Multiple myeloma' and 'MedlinePlus Genetics' on the study page. This is a minor metadata change and does not affect study details or user actions.
    Difference
    0.2%
    Check dated 2025-11-10T04:59:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows a refreshed layout and a newer update timestamp, while core trial details including design, eligibility criteria, and location listings appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:21:26.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The study page no longer displays the condition 'Multiple myeloma' and the related topic 'MedlinePlus Genetics'.
    Difference
    0.2%
    Check dated 2025-10-26T20:46:08.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic entry on Multiple Myeloma, narrowing the page’s scope and its genetics-related content.
    Difference
    0.3%
    Check dated 2025-10-19T16:30:14.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    5%
    Check dated 2025-10-05T10:19:17.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Update terminology from Plasma cell myeloma to Multiple myeloma and bump revision from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-28T03:18:31.000Z thumbnail image

Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.